Pediatric brain tumors refer to abnormal mass of cells in
the brain, which affects children aged between 0-14 years. These tumors can
either be benign or malignant. Some of the common types of pediatric brain
tumors include medulloblastoma, glioma, and astrocytoma. The growth and
development of pediatric brain tumors are different from adult brain tumors due
to anatomical and physiological differences between children and adults.
Treatment of pediatric brain tumors involve surgery, chemotherapy, radiation
therapy based on the type, size and location of the tumor. Early diagnosis play
a crucial role in improving the overall survival rates of pediatric brain
tumors.
The global pediatric
brain tumors market is estimated to be valued at US$ 296.2 million in 2024
and is expected to exhibit a CAGR of 6.9% over the forecast period 2024-2032.
Increasing prevalence of pediatric brain tumors due to
genetic factors and changing lifestyle is primarily driving the market growth.
As per WHO, over 4,000 children are diagnosed with pediatric brain tumors
annually in the US. In addition, rising number of brain tumor awareness
campaigns and improving diagnostics & screening facilities are further
propelling the demand for pediatric brain tumors treatment. However, high cost
associated with surgical procedures and lack of skilled healthcare
professionals is restraining the market growth.
Key Takeaways
Key players operating in the pediatric brain tumors market are Bayer AG,
Novartis AG, Abbott, Pfizer Inc., GE Healthcare, Philips Healthcare, Siemens
Healthineers, Toshiba Medical Systems Corporation, and Hitachi Medical
Corporation.
- Rising prevalence of pediatric brain tumors is increasing the demand for
better diagnostic and treatment options. As per a study, pediatric brain tumors
are the leading cause of cancer-related deaths among children aged below 15
years.
- Technological advancements in imaging techniques such as MRI, CT scan and
ultrasound are helping in early detection and diagnosis of pediatric brain
tumors. Availability of high field MRI with better resolution and advanced
software for image processing is further facilitating accurate diagnosis.
Market Trends
- Development of personalized medicine: Key players are focusing on
development of personalized therapies targeting specific tumor genetics and
molecular signatures to improve treatment outcomes.
- Adoption of targeted drug delivery systems: Incorporation of nanotechnology
and development of targeted drug delivery systems helps in precise delivery of
drugs to tumor sites, thereby reducing drug resistance and side effects
associated with chemotherapy.
Market Opportunities
- Emerging economies present major opportunities for players due to
improving healthcare infrastructure and increasing healthcare spending.
- Combination therapy approach combining surgery, radiation and chemotherapy
offers new growth prospects with higher cure rates and better survival
benefits.
Impact of COVID-19 on Pediatric Brain
Tumors Market Growth
The COVID-19 pandemic has adversely impacted the pediatric brain tumors market
globally. During the peak of the pandemic in 2020-2021, the number of new
pediatric brain tumor cases dropped significantly as people avoided hospitals
and deferred non-emergency medical procedures due to fear of contracting the
virus. This led to delays in diagnosis and impacted the overall market growth
negatively during this period. Furthermore, resource allocation towards treating
COVID-19 patients also hampered the availability of services and therapies for
pediatric brain tumors.
With restrictions now being lifted and vaccination drives in progress, the
market is witnessing a rebound. However, it is yet to reach the pre-pandemic
levels. Teleconsultation and home delivery of medicines have picked up to
ensure continuity of care. Hospitals and clinics are taking all necessary
precautions like screening, sanitization and social distancing to restore
patient confidence. Pharmaceutical companies are also ramping up production of
drugs and therapies to meet the growing demand. It is expected the market will
start growing at its earlier pace by 2023 as the effects of the pandemic
continue to subside.
North America accounts for the major share of the global pediatric brain tumors
market in terms of value. This is attributed to the rising incidence of
pediatric brain tumors, availability of advanced treatment options and high
healthcare spending in the region. Europe is the second largest market
globally. The Asia Pacific region is projected to witness the highest growth
during the forecast period due to improving access to healthcare facilities,
increasing awareness about pediatric brain tumors and growing research
activities in countries like India and China.
Get more insights on this topic : https://nouw.com/ajay100/pediatric-brain-tumors-market-estimated-to-witness-high-growth-owing-to-rising-incidence-of-brain-38620111
What
Are The Key Data Covered In This Pediatric Brain Tumors Market Report?
:- Market
CAGR throughout the predicted period
:- Comprehensive
information on the aspects that will drive the Pediatric Brain Tumors 's growth
between 2024 and 2031.
:- Accurate
calculation of the size of the Pediatric Brain Tumors and its contribution to the market, with
emphasis on the parent market
:- Realistic
forecasts of future trends and changes in consumer behaviour
:- Pediatric
Brain Tumors Industry Growth in North
America, APAC, Europe, South America, the Middle East, and Africa
:- A
complete examination of the market's competitive landscape, as well as
extensive information on vendors
:- Detailed
examination of the factors that will impede the expansion of Pediatric Brain
Tumors vendors
About Author:
Ravina Pandya, Content Writer, has a strong foothold
in the market research industry. She specializes in writing well-researched
articles from different industries, including food and beverages, information
and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1. Source:
Coherent Market Insights, Public sources, Desk research
2. We
have leveraged AI tools to mine information and compile it
Comments
Post a Comment